Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia

Blood (2014) 124 (1): 42–48.

https://doi.org/10.1182/blood-2014-02-555722

Published: 2014

Includes: Supplemental data

Journal Articles

Differential DNA Methylation Predicts Response To Combined Treatment Regimens With a DNA Methyltransferase Inhibitor In Acute Myeloid Leukemia (AML)

Maximilian Schmutz, Manuela Zucknick, PhD, Richard F. Schlenk, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Christoph Plass, PhD, Lars Bullinger, MD, PhD, Rainer Claus, MD

Blood (2013) 122 (21): 2539.

https://doi.org/10.1182/blood.V122.21.2539.2539

Published: 2013

Journal Articles

Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia

Christopher C Oakes, Ph.D, Rainer Claus, MD, Lei Gu, Yassen Assenov, Jennifer Hüllein, Manuela Zucknick, David Brocks, Olga Bogatyrova, Christopher R. Schmidt, Laura Rassenti, PhD, Thomas J. Kipps, MD, PhD, Daniel Mertens, PhD, Peter Lichter, PhD, Hartmut Döhner, MD, Stephan Stilgenbauer, MD, John C. Byrd, MD, Thorsten Zenz, MD, Christoph Plass, PhD

Blood (2013) 122 (21): 1626.

https://doi.org/10.1182/blood.V122.21.1626.1626

Published: 2013

Journal Articles

The Relative Significance of ZAP -70 Promoter Methylation As a Prognostic Factor in Previously Untreated Chronic Lymphocytic Leukemia: Validation of Results Using a Second Large CLL Research Consortium (CRC) Patient Data Set

Rainer Claus, MD, Amy S. Ruppert, MAS, David M. Lucas, PhD, Manuela Zucknick, PhD, Laura Z. Rassenti, Ph.D., Andrew Greaves, Donna S. Neuberg, ScD, William G. Wierda, MD, Ph.D., Michael J. Keating, MD, Jennifer R. Brown, MD, PhD, John G Gribben, Kanti R. Rai, M.D., Michael R. Grever, MD, Neil E. Kay, MD, Thomas J. Kipps, MD, PhD, Christoph Plass, PhD, John C. Byrd, MD

Blood (2012) 120 (21): 3865.

https://doi.org/10.1182/blood.V120.21.3865.3865

Published: 2012

Journal Articles

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

Blood (2012) 119 (2): 551–558.

https://doi.org/10.1182/blood-2011-07-367508

Published: 2012

Includes: Supplemental data

Journal Articles

Decitabine (DAC) Treatment Induces Very Early In Vivo DNA Methylation and Transcriptome Changes in Primary AML Peripheral Blood Blasts

Rainer Claus, Dietmar Pfeifer, PhD, Maika Almstedt, Björn Hackanson, Manuela Zucknick, PhD, Christoph Plass, Michael Lübbert

Blood (2011) 118 (21): 1360.

https://doi.org/10.1182/blood.V118.21.1360.1360

Published: 2011

Journal Articles

Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome

Blood (2011) 117 (18): 4871–4880.

https://doi.org/10.1182/blood-2010-08-298968

Published: 2011

Includes: Supplemental data

Journal Articles

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Blood (2011) 117 (7): 2137–2145.

https://doi.org/10.1182/blood-2010-08-301713

Published: 2011

Includes: Supplemental data

Journal Articles

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

Verena I. Gaidzik, M.D., Cailian Wang, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Peter Paschka, M.D., Frank G. Rücker, M.D., Andrea Corbacioglu, Ph.D., Karina Eiwen, Jürgen Krauter, M.D., Brigitte Schlegelberger, MD, Arnold Ganser, M.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Hartmut Döhner, M.D., Konstanze Döhner, M.D.

Blood (2009) 114 (22): 1600.

https://doi.org/10.1182/blood.V114.22.1600.1600

Published: 2009

Journal Articles

Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG).

Peter Paschka, M.D., Juan Du, M.D., Richard F. Schlenk, M.D., Verena I. Gaidzik, M.D., Lars Bullinger, M.D., Andrea Corbacioglu, Ph.D., Manuela Zucknick, Ph.D., Axel Benner, M.Sc., Frank Stegelmann, M.D., Daniela Späth, Sabine Kayser, M.D., Brigitte Schlegelberger, M.D., Jürgen Krauter, M.D., Arnold Ganser, M.D., Hartmut Döhner, M.D., Konstanze Döhner, M.D.

Blood (2009) 114 (22): 824.

https://doi.org/10.1182/blood.V114.22.824.824

Published: 2009

Journal Articles

Mutations in the Fms-Related Tyrosine Kinase 3 (FLT3) Gene Independently Predict Poor Outcome in Acute Myeloid Leukemia (AML) with t(8;21): A Study of the German-Austrian AML Study Group (AMLSG).

Peter Paschka, M.D., Juan Du, M.D., Richard F. Schlenk, M.D., Lars Bullinger, M.D., Verena I. Gaidzik, M.D., Andrea Corbacioglu, Ph.D., Axel Benner, M.Sc., Manuela Zucknick, Ph.D., Frank Stegelmann, M.D., Daniela Späth, Sabine Kayser, M.D., Brigitte Schlegelberger, MD, Juergen Krauter, M.D., Arnold Ganser, M.D., Hartmut Döhner, Konstanze Döhner

Blood (2009) 114 (22): 825.

https://doi.org/10.1182/blood.V114.22.825.825

Published: 2009

Journal Articles

Comprehensive Protein Expression Analysis of Chronic Lymphocytic Leukemia Uncovers a Correlation of CDK4, P27 and P53 with Hierarchical Risk and Suggests a Dichotomy of Apoptosis and Proliferation.

Dirk Winkler, MD, Christof Schneider, MD, Daniela Nitsch, MD, Kerstin Schulze, Thorsten Zenz, MD, Julia Mohr, Andreas Buehler, MD, Annett Habermann, Manuela Zucknick, Axel Benner, Hartmut Döhner, MD, Stephan Stilgenbauer, MD, Daniel Mertens

Blood (2009) 114 (22): 1255.

https://doi.org/10.1182/blood.V114.22.1255.1255

Published: 2009

NARROW

Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia

Differential DNA Methylation Predicts Response To Combined Treatment Regimens With a DNA Methyltransferase Inhibitor In Acute Myeloid Leukemia (AML)

Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia

The Relative Significance of ZAP -70 Promoter Methylation As a Prognostic Factor in Previously Untreated Chronic Lymphocytic Leukemia: Validation of Results Using a Second Large CLL Research Consortium (CRC) Patient Data Set

Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

Decitabine (DAC) Treatment Induces Very Early In Vivo DNA Methylation and Transcriptome Changes in Primary AML Peripheral Blood Blasts

Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Analysis of the ETS Family Member Genes ERG, ETS2, ETS1 and FLI1 in Acute Myeloid Leukemia (AML) Patients with Normal Cytogenetics: Expression Levels and Impact On Clinical Outcome. A Study of the AMLSG.

Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG).

Mutations in the Fms-Related Tyrosine Kinase 3 (FLT3) Gene Independently Predict Poor Outcome in Acute Myeloid Leukemia (AML) with t(8;21): A Study of the German-Austrian AML Study Group (AMLSG).

Comprehensive Protein Expression Analysis of Chronic Lymphocytic Leukemia Uncovers a Correlation of CDK4, P27 and P53 with Hierarchical Risk and Suggests a Dichotomy of Apoptosis and Proliferation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only